Evidence map›Paper›PMID 32034865›Full record

ArticleTransplant infectious disease : an official journal of the Transplantation Society2020

Donor-derived transmission through lung transplantation of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 carbapenemase during an ongoing healthcare facility outbreak.

Ana C Bardossy, Emily A Snavely, Elizabeth Nazarian, Pallavi Annambhotla, Sridhar V Basavaraju, Dana Pepe, Meghan Maloney, Kimberlee A Musser, Wolfgang Haas, Nicolas Barros and 3 more

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Transplant infectious disease : an official journal of the Transplantation Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Ana C BardossyEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID https://orcid.org/0000-0002-3523-112X
Emily A SnavelyWadsworth Center, New York State Department of Health, Albany, NY, USA.
Elizabeth NazarianWadsworth Center, New York State Department of Health, Albany, NY, USA.
Pallavi AnnambhotlaDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Sridhar V BasavarajuDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Dana PepeYale School of Medicine, New Haven, CT, USA.
Meghan MaloneyConnecticut Department of Public Health, Healthcare-Associated Infections Antimicrobial Resistance Program, Hartford, CT, USA.
Kimberlee A MusserWadsworth Center, New York State Department of Health, Albany, NY, USA.
Wolfgang HaasWadsworth Center, New York State Department of Health, Albany, NY, USA.
Nicolas BarrosTransplant Infectious Diseases and Compromised Host Program, Massachusetts General Hospital, Boston, MA, USA.
Virginia M PierceMicrobiology Laboratory, Pathology Service, Massachusetts General Hospital, Boston, MA, USA.
Maroya WaltersDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lauren EpsteinDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Centers for Disease Control and Prevention · USNew York State Department of Health · USConnecticut Department of Public Health · USHarvard University · USMassachusetts General Hospital · USYale University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

We describe a rare instance of donor-derived OXA-23-producing carbapenem-resistant Acinetobacter baumannii transmission during lung transplantation and the subsequent public health response. This investigation highlights how transplantation can introduce rare multidrug-resistant organisms into different healthcare facilities and regions.

Indexed as

beta-Lactam ResistanceDisease OutbreaksTissue DonorsAcinetobacter baumanniiAcinetobacter Infectionsbeta-LactamasesCarbapenemsDrug Resistance, Multiple, BacterialGenotypeHealth FacilitiesHumansLung TransplantationMaleMicrobial Sensitivity TestsMiddle AgedPhenotypebeta-lactamase OXA-23beta-LactamasesCarbapenemscarbapenem-resistant Acinetobacter baumanniidonor-derived transmissionlung transplantation

Identifiers

PMID32034865
PMCPMC10833477
OpenAlexW3005150730

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.